These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 621200)

  • 41. Proton magnetic resonance study of lysine-binding to the kringle 4 domain of human plasminogen. The structure of the binding site.
    Ramesh V; Petros AM; Llinás M; Tulinsky A; Park CH
    J Mol Biol; 1987 Dec; 198(3):481-98. PubMed ID: 2828641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of tryptophan-74 of the recombinant kringle 2 domain of tissue-type plasminogen activator in its omega-amino acid binding properties.
    De Serrano VS; Castellino FJ
    Biochemistry; 1992 Apr; 31(13):3326-35. PubMed ID: 1554717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [FIBRINOLYSIS; APPLICATION IN THE CLINIC (EPSILON-AMINOCAPROIC ACID)].
    MOERS AM; BOSMAN GA
    Folia Med Neerl; 1964 Dec; 7():175-8. PubMed ID: 14265805
    [No Abstract]   [Full Text] [Related]  

  • 44. The control of the urokinase-catalyzed activation of human glutamic acid 1-plasminogen by positive and negative effectors.
    Urano T; Sator de Serrano V; Chibber BA; Castellino FJ
    J Biol Chem; 1987 Nov; 262(33):15959-64. PubMed ID: 3680236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system.
    Viedma-Rodríguez R; Martínez-Hernández MG; Flores-López LA; Baiza-Gutman LA
    Mol Cell Biochem; 2018 Jan; 437(1-2):65-80. PubMed ID: 28612231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
    Takada A; Ohashi H; Matsuda H; Takada Y
    Thromb Res; 1979; 14(6):915-23. PubMed ID: 473126
    [No Abstract]   [Full Text] [Related]  

  • 47. Plasminogen binding by oral streptococci from dental plaque and inflammatory lesions.
    Kinnby B; Booth NA; Svensäter G
    Microbiology (Reading); 2008 Mar; 154(Pt 3):924-931. PubMed ID: 18310038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preferential Acquisition and Activation of Plasminogen Glycoform II by PAM Positive Group A Streptococcal Isolates.
    De Oliveira DM; Law RH; Ly D; Cook SM; Quek AJ; McArthur JD; Whisstock JC; Sanderson-Smith ML
    Biochemistry; 2015 Jun; 54(25):3960-8. PubMed ID: 26029848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Importance of the interaction between plasminogen and fibrin for plasminogen activation by tissue-type plasminogen activator.
    Dunn FW; Deguchi K; Soria J; Soria C; Lijnen HR; Tobelem G; Caen J
    Thromb Res; 1984 Nov; 36(4):345-51. PubMed ID: 6543039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetics of plasmin activation of single chain urinary-type plasminogen activator (scu-PA) and demonstration of a high affinity interaction between scu-PA and plasminogen.
    Longstaff C; Clough AM; Gaffney PJ
    J Biol Chem; 1992 Jan; 267(1):173-9. PubMed ID: 1730585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid.
    Mathews II; Vanderhoff-Hanaver P; Castellino FJ; Tulinsky A
    Biochemistry; 1996 Feb; 35(8):2567-76. PubMed ID: 8611560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
    Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
    Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms.
    Burchiel KJ; Schmer G
    J Neurosurg; 1981 Jan; 54(1):12-5. PubMed ID: 7463112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The binding of antifibrinolytic amino acids to kringle-4-containing fragments of plasminogen.
    Cole KR; Castellino FJ
    Arch Biochem Biophys; 1984 Mar; 229(2):568-75. PubMed ID: 6703712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. METHOD FOR DETERMINING EPSILON-AMINOCAPROIC ACID (EACA) IN BLOOD PLASMA, BASED ON THE ANTIFIBRINOLYTIC PROPERTIES OF THIS COMPOUND.
    WOLOSOWICZ N; NIEWIAROWSKI S; CZEREPKO K
    Thromb Diath Haemorrh; 1964 Jan; 10():309-16. PubMed ID: 14113373
    [No Abstract]   [Full Text] [Related]  

  • 56. Direct identification of lysine-33 as the principal cationic center of the omega-amino acid binding site of the recombinant kringle 2 domain of tissue-type plasminogen activator.
    De Serrano VS; Sehl LC; Castellino FJ
    Arch Biochem Biophys; 1992 Jan; 292(1):206-12. PubMed ID: 1309292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Receptors for human plasminogen on gram-negative bacteria.
    Ullberg M; Kronvall G; Karlsson I; Wiman B
    Infect Immun; 1990 Jan; 58(1):21-5. PubMed ID: 1688419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Photoaffinity labeling of functionally different lysine-binding sites in human plasminogen and plasmin.
    Ryan TJ; Keegan MC
    Biochim Biophys Acta; 1985 Aug; 830(2):187-94. PubMed ID: 3160389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FTIR determination of ligand-induced secondary and tertiary structural changes in bovine plasminogen.
    Hayes KD; Ozen BF; Nielsen SS; Mauer LJ
    J Dairy Res; 2003 Nov; 70(4):461-6. PubMed ID: 14649418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
    Novokhatny V; Medved L; Lijnen HR; Ingham K
    J Biol Chem; 1995 Apr; 270(15):8680-5. PubMed ID: 7721771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.